Navigation Links
Luminex Corporation Reports Third Quarter 2011 Results
Date:11/1/2011

210%$
36,470$
,367$
36,10336%Consolidated revenue for the third quarter of 2011 was $45.6 million, a 34% increase over consolidated revenue of $33.9 million for the third quarter of 2010.  GAAP net income for the third quarter of 2011 was $1.9 million, or $0.05 per diluted share, compared with a GAAP net loss of $0.7 million, or $0.02 per diluted share, for the prior year period. Included in cost of sales for the current quarter are $2.0 million of costs associated with the fair valuation of EraGen inventory at acquisition, representing an approximate $0.05 per diluted share impact.  

Net income for the third quarter of 2011 included non-cash charges of $2.8 million in stock compensation expense associated with ASC 718 and $3.3 million of depreciation and amortization expense.  Net income for the third quarter of 2010 included non-cash charges of $2.3 million in stock compensation expense associated with ASC 718 and $2.2 million of depreciation and amortization expense.  

LUMINEX CORPORATIONREPORTABLE SEGMENT HIGHLIGHTS(in thousands, except percentages)Three Months EndedSeptember 30,Variance20112010($)(%)(unaudited)RevenueTechnology and strategic partnerships

$
29,918$
24,593$
5,32522%Assays and related products

15,6399,2806,35969%Total Revenue

45,55733,87311,68434%Operating income (loss)Technology and strategic partnerships

5,4282,1933,235148%Assays and related products

(2,608)(2,038)(570)-28%Total Operating income

2,8201552,6651719%Nine Months EndedSeptember 30,Variance20112010($)(%)(unaudited)RevenueTechnology and strategic partnerships

$
98,064$
75,036$
23,02831%Assays and related products

38,40625,33113,07552%Total Revenue

136,470100,36736,10336%Operating income (loss)Technology and strategic partnerships

25,65610,10515,551154%Assays and related products

(5,745)(3,937)(1,808)-46%Total Operating income

19,9116,1
'/>"/>

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Luminex Corporation Receives Deloitte Technology Fast 500™ Award
2. Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011
3. Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna
4. Luminex Corporation to Present at Upcoming Investment Conferences In September
5. Luminex Corporation Reports Second Quarter 2011 Results
6. Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test
7. Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011
8. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
9. Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System
10. Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc.
11. Luminex and Life Technologies Sign Agreement for Global Distribution of the Award-Winning MAGPIX® Multiplexing Instrument
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... NEWTON, Mass. and JERUSALEM ... privately-held biopharma company developing octreotide capsules, its lead product ... of a $70 million Series E financing round. Participants ... and Sofinnova Ventures, and an undisclosed blue chip public ... F2 Capital, 7 Med Health Ventures, Abingworth and ARCH ...
(Date:2/26/2015)... February 27, 2015 RnRMarketResearch.com ... market research report to its store. This report ... therapeutic pipeline. The report "Corneal Ulcers - Pipeline ... therapeutic development for Corneal Ulcers. Corneal Ulcers are ... bacterial infections, viral infections & fungal infections. The ...
(Date:2/26/2015)... , Feb. 26, 2015  Today the ... The psychological and physical side effects of pain ... opioid painkillers, such as Vicodin and Oxycontin, are safer ... Americans overdose on prescription painkillers than on heroin and ... and CEO of NSC. "Yet, these medications are marketed ...
Breaking Medicine Technology:Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2
... plc (LSE: SHP, Nasdaq: SHPGY ), the ... INTUNIV (guanfacine) extended release, a selective alpha-2A-agonist, at a ... its primary objective, which was to evaluate the effects ... to 12 years with a diagnosis of ADHD and ...
... MEDRAD Interventional(TM)/Possis(R) today announced that it has ... closer to market as an option for the ... and Europe who suffer from Peripheral Arterial Disease ... investigators for U.S. clinical trials and the completion ...
Cached Medicine Technology:Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms 2Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms 3Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms 4Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms 5Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 2Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 3Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 4Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 5
(Date:2/28/2015)... 28, 2015 Mew and Company, a ... they now provide business consulting services in addition to ... tax planning and succession planning. Company finances are a ... professionals. On top of this, complex Canadian tax laws ... accounting. As a result, Mew and Company works to ...
(Date:2/28/2015)... Bethesda, MD (PRWEB) February 28, 2015 ... will present its annual awards at the International Symposium ... Dinner will be held at the Hyatt Regency Bethesda ... honored for their dedicated work and commitment to the ... of the Year Award will be presented to Miriam ...
(Date:2/28/2015)... New York, NY (PRWEB) February 28, 2015 ... to discuss federal testosterone lawsuits that have been filed ... scheduled for the second week in March, the Firm ... the Court’s website, parties involved in the federal litigation ... to address matters related to prescription therapy treatments designed ...
(Date:2/28/2015)... The noted Toronto plastic surgeon Dr. ... recently featured in the January/February 2015 issue of Elevate ... Ellis was featured in an article entitled “Get the ... that Kim Cattrall has possibly undergone to maintain her ... smooth without horizontal lines or frown line creases, which ...
(Date:2/28/2015)... Memphis, TN: MedixSafe has retracted a previous announcement ... reader named Guardian 2. The correct product name ... scanner that significantly increases the complexity of security ... scanner provides fast and easy access for both ... lockers with Vanguard technology tracks inventory by ...
Breaking Medicine News(10 mins):Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:Dr. David Ellis Featured In Elevate Magazine 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2
... February 02, 2009 A new study published in ... of migraine in the U.S. and recent clinical findings ... study traces the history of economic articles published on ... of relevant articles to identify possible health risks associated ...
... consumer group today called upon Google to publicly disclose ... of the financial stimulus legislation, given a new account ... bill was felt on Capitol Hill.Consumer Watchdog called on ... letter follows:Robert Boorstin , Director of Corporate and Policy ...
... Rochester Medical Corporation (Nasdaq: ROCM ) today announced ... Company reported sales of $8,436,000 for the current quarter compared ... It also reported net income of $54,000 or $.00 per ... per diluted share for the first quarter of last year.The ...
... Tobacco use narrows blood vessels to fetus, study finds ... linking smoking during pregnancy to low birth weight has ... smoking during pregnancy lowers production of an enzyme called ... dilation. Reduced production of eNOS causes narrowing of blood ...
... getting them, study shows , , MONDAY, Feb. 2 (HealthDay ... may be popping vitamins and mineral supplements they don,t ... and mineral supplements are not considered necessary when a ... hand, children who actually need these supplements -- those ...
... adults who are heavy users of marijuana are ... development, according to a new study. Pediatric researchers ... interconnect brain regions involved in memory, attention, decision-making, ... of particular concern because adolescence is a crucial ...
Cached Medicine News:Health News:Study reviews health risks, economic burden of migraine 2Health News:Consumer Watchdog to Google: Publicly Disclose Your Lobbying Positions on Electronic Medical Record Provisions in Stimulus Bill 2Health News:Rochester Medical Reports First Quarter Results 2Health News:Rochester Medical Reports First Quarter Results 3Health News:Rochester Medical Reports First Quarter Results 4Health News:Rochester Medical Reports First Quarter Results 5Health News:Rochester Medical Reports First Quarter Results 6Health News:Rochester Medical Reports First Quarter Results 7Health News:Rochester Medical Reports First Quarter Results 8Health News:Smoking-Low Birth Weight Link Explained in Part 2Health News:Many Kids Don't Need the Vitamins They're Taking 2Health News:Many Kids Don't Need the Vitamins They're Taking 3Health News:Heavy marijuana use may damage developing brain in teens, young adults 2
... The Aircast Knee Immobilizer is designed to ... rigid posterior splint comfortably stabilizes the knee ... provide a space behind the knee, even ... lightweight design, and non-slip comfort, the Knee ...
Designed to provide continuous cold therapy to the shoulder and back. Helps to reduce pain and swelling and speed rehab....
Indicated for treatment of patella instability...
OmoTrain is a unique support for the shoulder that promotes mobility and limits rotation....
Medicine Products: